Tarsus Pharmaceuticals Inc. logo

Tarsus Pharmaceuticals Inc.

TARS | NASDAQ
Chart Builder DCF Calculator
$77.46
-$0.63 (-0.81%)
At close: Sep 21, 2026, 4:00 PM ET
$77.46
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
183.64M 94.82M 224.95M 71.66M 171.33M 168.13M
Short-Term Investments
233.63M 196.56M 2.5M 145.37M 483K n/a
Long-Term Investments
3.87M 3M 631K 371K 663K n/a
Other Long-Term Assets
6.4M 6.09M 1.51M 585K 463K 81K
Receivables
87.11M 48.06M 17.71M 3.58M 92K 20K
Inventory
4.37M 2.62M 3.11M n/a n/a n/a
Other Current Assets
560K n/a n/a n/a n/a 20K
Total Current Assets
522.78M 356.71M 256.13M 225.38M 175.95M 170.66M
Property-Plant & Equipment
21.75M 2.87M 3.35M 1.53M 1.83M 1.24M
Goodwill & Intangibles
7.37M 8.33M 3.87M n/a n/a n/a
Total Long-Term Assets
39.38M 20.29M 9.36M 2.49M 2.96M 1.32M
Total Assets
562.16M 376.99M 265.49M 227.86M 178.91M 171.97M
Account Payables
16.39M 27.74M 17.77M 5.5M 2.86M 2.24M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
117.5M n/a n/a n/a 56K 304K
Total Current Liabilities
135.7M 80.61M 36.94M 15.43M 11.48M 5.39M
Long-Term Debt
83.04M 71.85M 29.82M 19.43M n/a n/a
Other Long-Term Liabilities
-10.6M n/a 1.75M 48K 114K 56K
Total Long-Term Liabilities
83.04M 71.85M 31.57M 19.53M 699K 605K
Total Liabilities
218.73M 152.46M 68.5M 34.96M 12.18M 5.99M
Total Debt
93.64M 72.45M 30.22M 20.21M 1.89M 831K
Book Value
343.43M 224.53M 196.99M 192.9M 166.73M 165.98M
Book Value Per Share
8.22 5.97 6.70 7.84 8.11 8.17
Common Stock
6K 6K 5K 5K 4K 4K
Retained Earnings
-426.63M -360.21M -244.66M -108.76M -46.67M -32.85M
Comprehensive Income
381K 179K -2K -74K n/a n/a
Shareholders Equity
343.43M 224.53M 196.99M 192.9M 166.73M 165.98M
Total Investments
237.5M 199.56M 3.13M 145.74M 1.15M n/a

© 2026 bestshares.com. All rights reserved.